These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 29453694)

  • 1. Percutaneous left atrial appendage occlusion in the prevention of stroke in atrial fibrillation: a systematic review.
    Baman JR; Mansour M; Heist EK; Huang DT; Biton Y
    Heart Fail Rev; 2018 Mar; 23(2):191-208. PubMed ID: 29453694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
    Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
    PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous left atrial appendage closure: procedural techniques and outcomes.
    Saw J; Lempereur M
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1205-20. PubMed ID: 25459035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
    Bing S; Chen RR
    Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Occlusion Device Implantation: the Role of the Echocardiographer.
    Altszuler D; Vainrib AF; Bamira DG; Benenstein RJ; Aizer A; Chinitz LA; Saric M
    Curr Cardiol Rep; 2019 Jun; 21(7):66. PubMed ID: 31183616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrial Appendage Occlusion for Stroke Prevention.
    Chanda A; Reilly JP
    Prog Cardiovasc Dis; 2017; 59(6):626-635. PubMed ID: 28457791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Appendage Occlusion: The Current Device Landscape and Future Perspectives.
    Cruz-Gonzalez I; Fuertes-Barahona M; Moreno-Samos JC; Gonzalez-Ferreiro R; Lam YY; Sanchez PL
    Interv Cardiol Clin; 2018 Apr; 7(2):253-265. PubMed ID: 29526293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet.
    Kleinecke C; Park JW; Gödde M; Zintl K; Schnupp S; Brachmann J
    Cardiol J; 2017; 24(2):131-138. PubMed ID: 28198520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.
    Freeman JV; Hutton DW; Barnes GD; Zhu RP; Owens DK; Garber AM; Go AS; Hlatky MA; Heidenreich PA; Wang PJ; Al-Ahmad A; Turakhia MP
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27307517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
    Onalan O; Crystal E
    Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.